Chlortetracycline

Chlortetracycline

SCHEMBL3842

CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)ccc(Cl)c4[C@@](C)(O)[C@H]3C[C@H]12.Cl

nearest known ligand 0.71

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Chlortetracycline. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 10/20 0.71
KMT2A Q03164 10/20 0.71
TDP1 Q9NUW8 7/20 0.71
MAPT P10636 6/20 0.71
USP2 O75604 5/20 0.71
HSD17B10 Q99714 4/20 0.71
GAA P10253 3/20 0.71
ALDH1A1 P00352 3/20 0.71
HPGD P15428 2/20 0.71
POLB P06746 3/20 0.70
LMNA P02545 3/20 0.70
THRB P10828 2/20 0.70
PLA2G1B P04054 1/20 0.70
ATG4B Q9Y4P1 1/20 0.70
HIF1A Q16665 1/20 0.70
PDE4A P27815 1/20 0.70
PADI4 Q9UM07 1/20 0.70
KDM4E B2RXH2 6/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
CYP3A4 P08684 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Chlortetracycline SCHEMBL29362279 1.00 MEN1 (0.71) MEN1KMT2ATDP1MAPTUSP2
Chlortetracycline SCHEMBL3841 1.00 MEN1 (0.71) MEN1KMT2ATDP1MAPTUSP2
Chlortetracycline SCHEMBL13782533 0.99 MAPT (0.71) MEN1KMT2ATDP1MAPTUSP2
Chlortetracycline SCHEMBL5503038 0.99 MAPT (0.71) MEN1KMT2ATDP1MAPTUSP2
Chlortetracycline SCHEMBL13782583 0.99 MAPT (0.71) MEN1KMT2ATDP1MAPTUSP2
Chlortetracycline SCHEMBL16726392 0.99 MAPT (0.71) MEN1KMT2ATDP1MAPTUSP2
Chlortetracycline SCHEMBL10901448 0.99 MAPT (0.71) MEN1KMT2ATDP1MAPTUSP2
Chlortetracycline SCHEMBL3110 0.99 MAPT (0.71) MEN1KMT2ATDP1MAPTUSP2
Chlortetracycline SCHEMBL20952683 0.99 MAPT (0.71) MEN1KMT2ATDP1MAPTUSP2
Chlortetracycline SCHEMBL12356689 0.99 MAPT (0.71) MEN1KMT2ATDP1MAPTUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3358 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122071006-A Urea modified Bi2O3/g-C3N4Heterojunction catalyst and preparation method and application thereof 武汉纺织大学 2026-05-22 CN claimed
CN-120131995-A Aureomycin hydrochloride clathrate, preparation method and application thereof, aureomycin hydrochloride injection and application thereof 浦城正大生化有限公司 2025-06-13 CN claimed
WO-2025085377-A1 USE OF ZOALENE IN LIVESTOCK ZOETIS SERVICES LLC (US) 2025-04-24 WO claimed
US-12274830-B2 Nitric oxide inhalation therapy for infants with bronchiolitis BEYOND AIR LTD (IL) 2025-04-15 US claimed
CN-119657164-A One-step in-situ preparation of compact-interface Z-type NiMn2O4Method for preparing NiO composite photocatalyst and application thereof 辽宁大学 2025-03-21 CN claimed
CN-119346140-A Bi plasma loaded Bi24O31Br10Nanosheet photocatalyst and preparation method and application thereof 广东工业大学 2025-01-24 CN claimed
CN-119242301-A Oil residue carbon dot, preparation method and application thereof in detection of mercury ions and aureomycin hydrochloride 昆明市延安医院(昆明市干部疗养院) 2025-01-03 CN claimed
CN-116120202-B Crystallization preparation method of high-water-soluble aureomycin hydrochloride 浦城正大生化有限公司 2024-12-24 CN claimed
CN-119000630-A Quantitative detection method of aureomycin hydrochloride 湖南科技大学 2024-11-22 CN claimed
CN-118988367-A C with nitrogen defect and no metal flower cluster3N4Photocatalyst, preparation method and application thereof in degradation of tetracycline antibiotics 浙江爱迪曼环保科技股份有限公司 2024-11-22 CN claimed
WO-1997006782-A1 COMPOSITIONS INCLUDING O-CARBOXYALKYL CHITOSAN AND METHODS OF USE IN OPHTHALMICS NOVARTIS AG (CH) 1997-02-27 WO claimed
WO-1997000669-A1 COMPOSITIONS AND METHODS FOR STABILIZING POLYMERS NOVARTIS AG (CH) 1997-01-09 WO claimed
EP-0741570-A1 METHOD FOR PREVENTING OR REDUCING PHOTOSENSITIVITY AND/OR PHOTOTOXICITY REACTIONS TO MEDICATIONS G.D. SEARLE & CO. (US) 1996-11-13 EP claimed
WO-1995020387-A1 METHOD FOR PREVENTING OR REDUCING PHOTOSENSITIVITY AND/OR PHOTOTOXICITY REACTIONS TO MEDICATIONS G.D. SEARLE & CO. (US) 1995-08-03 WO claimed
US-5357636-A Flexible protective medical gloves and methods for their use DRESDNER JR KARL P (US) 1994-10-25 US claimed
EP-0201057-B1 BONE TARGETED INHIBITORS OF CARBONIC ANHYDRASE RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1992-12-02 EP claimed
US-5167964-A Coating of blend of ethyl acrylate-methacrylic acid copolymer and povidone WARNER-LAMBERT COMPANY (US) 1992-12-01 US claimed
EP-0201057-A2 Bone targeted inhibitors of carbonic anhydrase RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1986-11-12 EP claimed
US-4126680-A TETRACYCLINE ANTIBIOTIC COMPOSITIONS PFIZER INC. (US) 1978-11-21 US claimed
US-4081527-A Chlortetracycline compositions PFIZER INC. (US) 1978-03-28 US claimed